Susquehanna International Group’s Lantern Pharma LTRN Stock Holding History

Susquehanna International Group’s Portfolio LTRN Stock Details LTRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28,820	Closed	-$87.3K	–	13701
2025 Q4	$87.3K	Sell	28,820 -10,274	-26%	-$38.2K	﹤0.01%	11528
2025 Q3	$170K	Buy	+39,094	New	+$163K	﹤0.01%	11153
2025 Q2	–	Sell	-14,949	Closed	-$52.9K	–	13272
2025 Q1	$52.9K	Sell	14,949 -11,352	-43%	-$47.1K	﹤0.01%	11841
2024 Q4	$83.9K	Buy	26,301 +4,420	+20%	+$15.1K	﹤0.01%	11446
2024 Q3	$80.3K	Sell	21,881 -37,878	-63%	-$156K	﹤0.01%	11169
2024 Q2	$279K	Buy	59,759 +33,975	+132%	+$204K	﹤0.01%	9617
2024 Q1	$227K	Buy	+25,784	New	+$138K	﹤0.01%	10337
2023 Q3	–	Sell	-10,581	Closed	-$59.7K	–	12543
2023 Q2	$59.7K	Buy	+10,581	New	+$54.7K	﹤0.01%	11260
2022 Q4	–	Sell	-14,558	Closed	-$70K	–	13144
2022 Q3	$70K	Buy	+14,558	New	+$78.3K	﹤0.01%	11992
2022 Q1	–	Sell	-10,439	Closed	-$83K	–	13568
2021 Q4	$83K	Sell	10,439 -470	-4%	-$4.29K	﹤0.01%	12262
2021 Q3	$122K	Buy	+10,909	New	+$141K	﹤0.01%	11939

Other funds holding LTRN

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Susquehanna International Group's LTRN Position: Q1 2026 in Review

Susquehanna International Group sold out of Lantern Pharma (LTRN) in Q1 2026, closing a stake of 28,820 shares — an estimated $87.3K sold.

Susquehanna International Group first reported a position in LTRN in Q3 2021 and held it in 11 quarters. The position peaked at $279K in Q2 2024. 33 funds tracked by Wall St. Rank hold LTRN as of Q1 2026.

Susquehanna International Group reported no remaining Lantern Pharma position as of Q1 2026 after selling out during the quarter.
Susquehanna International Group sold 28,820 Lantern Pharma shares in Q1 2026, an estimated $87.3K.
Susquehanna International Group first reported a position in Lantern Pharma in Q3 2021 and held it in 11 quarters.
Susquehanna International Group's Lantern Pharma position peaked at $279K in Q2 2024.
33 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.